Immuron Ltd Files 6-K for October 2025
Ticker: IMRN · Form: 6-K · Filed: Oct 24, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 24, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K, foreign-private-issuer
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed its October 6-K, confirming 20-F filing and no 12g3-2(b) info.
AI Summary
Immuron Limited filed a Form 6-K on October 24, 2025, reporting on its activities for the month of October 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. It also confirms that Immuron Limited is not furnishing information under Rule 12g3-2(b).
Why It Matters
This filing provides an update on Immuron Limited's regulatory status and reporting obligations with the SEC, which is important for investors tracking the company's compliance and disclosure practices.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (6-K) that does not contain new financial or operational information, thus posing minimal immediate risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 0001213900-25-101838.txt (document) — Filing identifier
- 20251024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
- Rule 12g3-2(b) (regulation) — SEC rule
FAQ
What is the primary purpose of this Form 6-K filing by Immuron Limited?
The Form 6-K is a Report of Foreign Private Issuer filed for the month of October 2025, providing updates on the company's activities and regulatory status.
Does Immuron Limited file its annual reports under Form 20-F or Form 40-F?
Immuron Limited indicates it files annual reports under cover of Form 20-F.
Is Immuron Limited furnishing information to the SEC pursuant to Rule 12g3-2(b)?
No, Immuron Limited has indicated that it is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the filing date of this Form 6-K?
The Form 6-K was filed as of October 24, 2025.
Where is Immuron Limited's principal executive office located?
Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Stats: 311 words · 1 min read · ~1 pages · Grade level 18.1 · Accepted 2025-10-23 20:01:15
Filing Documents
- ea0262385-6k_immuron.htm (6-K) — 12KB
- ea026238501ex99-1_immuron.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- ex99-1_002.jpg (GRAPHIC) — 7KB
- ex99-1_003.jpg (GRAPHIC) — 7KB
- ex99-1_004.jpg (GRAPHIC) — 3KB
- 0001213900-25-101838.txt ( ) — 57KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 24, 2025 titled: - Immuron launch PROIBS for IBS - A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron launch PROIBS for IBS 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 24, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3